Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial-Reference-Cited by-同舟云学术

Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial

Published:2023-06 Issue:6 Volume:43 Page:447-461
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Garcia-Huidobro Diego^ORCID,Iturriaga Carolina,Perez-Mateluna Guillermo,Fajuri Paula,Severino Nicolás,Urzúa Marcela,Fraga Juan Pablo,de la Cruz Javiera,Poli Cecilia,Castro-Rodríguez José A.,Fish Eleanor,Borzutzky Arturo,Pablo Olivo Juan,Suisbert Katherine,Cruz Andrea,Perez Katterine,Valdivieso Romina,Navarro Diego,Pereira Francisco,Monge Vanessa,Dibarrart Marisol,Salazar Krisbeth,Bracho Morgan,Pontanilla Lidia,

Funder

Altum Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-023-01278-3.pdf

Reference38 articles.

1. World Health Organization. WHO coronavirus (COVID-19) dashboard. Available from: https://covid19.who.int/. [Accessed 23 May 2023].

2. Bueno SM, Abarca K, González PA, et al. Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile. Clin Infect Dis. 2022;75(1):e792-804. https://doi.org/10.1093/cid/ciab823.

3. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Eng J Med. 2020;383(27):2603–15. https://doi.org/10.1056/nejmoa2034577.

4. Shertel T, Lange NW, Salerno DM, et al. Bebtelovimab for treatment of COVID-19 in ambulatory solid organ transplant recipients. Transplantation. 2022;106(10):e463–4. https://doi.org/10.1097/TP.0000000000004278.

5. Levin MJ, Ustianowski A, de Wit S, et al. Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19. N Engl J Med. 2022;386(23):2188–200. https://doi.org/10.1056/nejmoa2116620.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD;Respiratory Research;2024-05-29

2. PLGA nanoparticles for nasal drug delivery;Journal of Drug Delivery Science and Technology;2024-05